{
    "startDate": "2018-01-01",
    "endDate": "2018-12-31",
    "year": "2018",
    "quarter": "FY",
    "symbol": "SPPI",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 157480000
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
                "unit": "usd",
                "value": 46508000
            },
            {
                "label": "Accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 29873000
            },
            {
                "label": "Other receivables",
                "concept": "OtherReceivables",
                "unit": "usd",
                "value": 3698000
            },
            {
                "label": "Inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 3550000
            },
            {
                "label": "Prepaid expenses and other assets",
                "concept": "PrepaidExpenseCurrent",
                "unit": "usd",
                "value": 9579000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 250688000
            },
            {
                "label": "Property and equipment, net of accumulated depreciation",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 385000
            },
            {
                "label": "Intangible assets, net of accumulated amortization",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 111594000
            },
            {
                "label": "Goodwill [Line Items]",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 18061000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 10158000
            },
            {
                "label": "Current assets:",
                "concept": "Assets",
                "unit": "usd",
                "value": 390886000
            },
            {
                "label": "Accounts payable and other accrued liabilities",
                "concept": "AccountsPayableAndOtherAccruedLiabilities",
                "unit": "usd",
                "value": 69460000
            },
            {
                "label": "Accrued payroll and benefits",
                "concept": "AccruedEmployeeBenefitsCurrent",
                "unit": "usd",
                "value": 9853000
            },
            {
                "label": "Contract liabilities",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 4850000
            },
            {
                "label": "Deferred revenue",
                "concept": "DeferredRevenueCurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "FOLOTYN development liability",
                "concept": "sppi:AccruedDrugDevelopmentCosts",
                "unit": "usd",
                "value": 2311000
            },
            {
                "label": "Convertible senior notes",
                "concept": "SeniorNotesCurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 86474000
            },
            {
                "label": "FOLOTYN development liability, less current portion",
                "concept": "sppi:AccruedDrugDevelopmentCostsNoncurrent",
                "unit": "usd",
                "value": 9686000
            },
            {
                "label": "Deferred revenue, less current portion",
                "concept": "ContractWithCustomerLiabilityNoncurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Acquisition-related contingent obligations",
                "concept": "BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized",
                "unit": "usd",
                "value": 4345000
            },
            {
                "label": "Deferred tax liabilities",
                "concept": "DeferredIncomeTaxLiabilitiesNet",
                "unit": "usd",
                "value": 1469000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "sppi:ContingentObligationsRelatedToAcquisition",
                "unit": "usd",
                "value": 5650000
            },
            {
                "label": "Current liabilities:",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 107624000
            },
            {
                "label": "Commitments and Contingencies Disclosure [Abstract]",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Common stock, $0.001 par value; 300,000,000 shares authorized; 110,525,141 and 100,742,735 issued and outstanding at December 31, 2018 and 2017, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 110000
            },
            {
                "label": "Additional Paid-In Capital [Member]",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 886740000
            },
            {
                "label": "Accumulated other comprehensive (loss) income",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -3702000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -599886000
            },
            {
                "label": "Beginning Balance",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 283262000
            },
            {
                "label": "Total liabilities and stockholders\u2019 equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 390886000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -120011000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 28409000
            },
            {
                "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 17483000
            },
            {
                "label": "Accretion of debt discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": 1931000
            },
            {
                "label": "Amortization of debt issuance costs",
                "concept": "WriteOffOfDeferredDebtIssuanceCost",
                "unit": "usd",
                "value": 220000
            },
            {
                "label": "Bad debt expense (recovery)",
                "concept": "ProvisionForDoubtfulAccounts",
                "unit": "usd",
                "value": 12000
            },
            {
                "label": "Unrealized loss (gains) from transactions denominated in foreign currency",
                "concept": "ForeignCurrencyTransactionGainLossUnrealized",
                "unit": "usd",
                "value": -10000
            },
            {
                "label": "Loss on 2018 Convertible Note purchase (Note 15)",
                "concept": "sppi:GainLossOnRepurchaseOfNote",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Change in cash surrender value of corporate-owned life insurance policy",
                "concept": "LifeInsuranceCorporateOrBankOwnedChangeInValue",
                "unit": "usd",
                "value": 5000
            },
            {
                "label": "Deferred tax liabilities",
                "concept": "sppi:IncreaseDecreaseInDeferredTaxLiabilities",
                "unit": "usd",
                "value": 31000
            },
            {
                "label": "Income tax recognition on unrealized gain for available-for-sale securities",
                "concept": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Equity securities, unrealized gain (loss)",
                "concept": "EquitySecuritiesFvNiUnrealizedGain",
                "unit": "usd",
                "value": 10458000
            },
            {
                "label": "Change in fair value of contingent consideration related to acquisitions",
                "concept": "sppi:ChangeOfBusinessAcquisitionContingentConsiderationAtFairValue",
                "unit": "usd",
                "value": 1927000
            },
            {
                "label": "Research and development expense recognized for the value of common stock issued in connection with QAPZOLA (Note 17(b)(x)) and ROLONTIS (Note 17(b)(xiii)) milestone achievements",
                "concept": "OtherResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Accounts receivable, net",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -2844000
            },
            {
                "label": "Other receivables",
                "concept": "IncreaseDecreaseInOtherReceivables",
                "unit": "usd",
                "value": 1571000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": -3390000
            },
            {
                "label": "Prepaid expenses",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 3642000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": -5010000
            },
            {
                "label": "Accounts payable and other accrued obligations",
                "concept": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 11382000
            },
            {
                "label": "Accrued payroll and benefits",
                "concept": "IncreaseDecreaseInEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": 592000
            },
            {
                "label": "FOLOTYN development liability",
                "concept": "sppi:IncreaseDecreaseInAccruedDrugDevelopmentCosts",
                "unit": "usd",
                "value": -389000
            },
            {
                "label": "Acquisition-related contingent obligations",
                "concept": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Contract liabilities",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": 4850000
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Other long-term liabilities",
                "concept": "sppi:IncreaseDecreaseInOtherLongTermLiabilities",
                "unit": "usd",
                "value": -564000
            },
            {
                "label": "Cash Flows From Operating Activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -62403000
            },
            {
                "label": "Proceeds from redemption of corporate-owned life insurance policy",
                "concept": "ProceedsFromLifeInsurancePolicies",
                "unit": "usd",
                "value": 4130000
            },
            {
                "label": "Payment for corporate-owned life insurance premiums",
                "concept": "PaymentsToAcquireLifeInsurancePolicies",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 107000
            },
            {
                "label": "Cash paid for KHAPZORY distribution rights (Note 3(g))",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 2650000
            },
            {
                "label": "Purchase of equity securities (Note 11)",
                "concept": "PaymentsToAcquireInvestments",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash Flows From Investing Activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 1373000
            },
            {
                "label": "Proceeds from employees for exercises of stock options, net",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 13475000
            },
            {
                "label": "Proceeds from sale of stock under our employee stock purchase plan",
                "concept": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
                "unit": "usd",
                "value": 1122000
            },
            {
                "label": "Proceeds from employees, for our remittance to tax authorities, upon vesting of restricted stock",
                "concept": "sppi:ProceedsReceivedFromEmployeesRelatedtoSharebasedPaymentAwards",
                "unit": "usd",
                "value": 4645000
            },
            {
                "label": "Payments to tax authorities upon employees' surrender of restricted stock at vesting and exercises of stock options",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 27679000
            },
            {
                "label": "Payment of principal upon the maturity of the 2018 Convertible Notes (Note 15)",
                "concept": "RepaymentsOfConvertibleDebt",
                "unit": "usd",
                "value": 20000
            },
            {
                "label": "Payment of contingent consideration related to EVOMELA acquisition (Note 10(b))",
                "concept": "PaymentsForPreviousAcquisition",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Purchase of 2018 Convertible Notes (Note 15)",
                "concept": "RepaymentsOfNotesPayable",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Purchase of warrants related to the conversion hedge of 2018 Convertible Notes (Note 15)",
                "concept": "PaymentsForRepurchaseOfWarrants",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Proceeds from sale of call options related to the conversion hedge of 2018 Convertible Notes (Note 15)",
                "concept": "ProceedsFromHedgeFinancingActivities",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Proceeds from stock",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Dividends paid upon conversion of Series E Convertible Voting Preferred Stock (Note 7)",
                "concept": "PaymentsOfDividendsPreferredStockAndPreferenceStock",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash Flows From Financing Activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -8457000
            },
            {
                "label": "Effect of exchange rates on cash and equivalents",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations",
                "unit": "usd",
                "value": -356000
            },
            {
                "label": "Net (decrease) increase in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": -69843000
            },
            {
                "label": "Cash paid for income taxes",
                "concept": "IncomeTaxesPaid",
                "unit": "usd",
                "value": 45000
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 1031000
            }
        ],
        "ic": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -120011000
            },
            {
                "label": "Unrealized loss on available-for-sale securities, net of income tax expense of $0, $2.2 million and $0 for the years ended December 31, 2018, 2017, and 2016, respectively",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Foreign currency translation adjustments",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": -2490000
            },
            {
                "label": "Other comprehensive income (loss), net",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": -2490000
            },
            {
                "label": "Total comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -122501000
            },
            {
                "label": "Total revenues",
                "concept": "RevenueFromContractWithCustomerIncludingAssessedTax",
                "unit": "usd",
                "value": 109333000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 90700000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 94956000
            },
            {
                "label": "Amortization of intangible assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 28098000
            },
            {
                "label": "Operating costs and expenses:",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 240510000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -131177000
            },
            {
                "label": "Interest expense, net",
                "concept": "InterestIncomeExpenseNet",
                "unit": "usd",
                "value": -340000
            },
            {
                "label": "Change in fair value of contingent consideration related to acquisitions",
                "concept": "sppi:ChangeOfBusinessAcquisitionContingentConsiderationAtFairValue",
                "unit": "usd",
                "value": 1927000
            },
            {
                "label": "Other income, net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 9580000
            },
            {
                "label": "Other income (expense):",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 11167000
            },
            {
                "label": "Loss before income taxes",
                "concept": "IncomeLossAttributableToParent",
                "unit": "usd",
                "value": -120010000
            },
            {
                "label": "(Provision) benefit for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 1000
            },
            {
                "label": "Net loss per share-basic ($ per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -1.16
            },
            {
                "label": "Net loss per share-diluted ($ per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -1.16
            },
            {
                "label": "Weighted average shares-basic (shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 103305911
            },
            {
                "label": "Weighted average shares-diluted (shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 103305911
            }
        ]
    }
}